dollar general headache powders
Generic: aspirin and caffeine
Labeler: dolgencorp, llcDrug Facts
Product Profile
Brand Name
dollar general headache powders
Generic Name
aspirin and caffeine
Labeler
dolgencorp, llc
Dosage Form
POWDER
Routes
Active Ingredients
aspirin 845 mg/1, caffeine 65 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
55910-695
Product ID
55910-695_89e6945c-1b9d-4def-889e-a37f33ca8c48
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M013
Listing Expiration
2026-12-31
Marketing Start
2021-03-31
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
55910695
Hyphenated Format
55910-695
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
dollar general headache powders (source: ndc)
Generic Name
aspirin and caffeine (source: ndc)
Application Number
M013 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 845 mg/1
- 65 mg/1
Packaging
- 18 PACKET in 1 CARTON (55910-695-18) / 1 POWDER in 1 PACKET
- 24 PACKET in 1 CARTON (55910-695-50) / 1 POWDER in 1 PACKET
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "89e6945c-1b9d-4def-889e-a37f33ca8c48", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0023513113104"], "unii": ["R16CO5Y76E", "3G6A5W338E"], "rxcui": ["994435"], "spl_set_id": ["11b0271b-d65c-49c4-a081-d71044a0e04c"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Dolgencorp, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "18 PACKET in 1 CARTON (55910-695-18) / 1 POWDER in 1 PACKET", "package_ndc": "55910-695-18", "marketing_start_date": "20210331"}, {"sample": false, "description": "24 PACKET in 1 CARTON (55910-695-50) / 1 POWDER in 1 PACKET", "package_ndc": "55910-695-50", "marketing_start_date": "20210331"}], "brand_name": "Dollar General Headache Powders", "product_id": "55910-695_89e6945c-1b9d-4def-889e-a37f33ca8c48", "dosage_form": "POWDER", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "55910-695", "generic_name": "Aspirin and Caffeine", "labeler_name": "Dolgencorp, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Dollar General Headache Powders", "active_ingredients": [{"name": "ASPIRIN", "strength": "845 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210331", "listing_expiration_date": "20261231"}